Literature DB >> 2159245

Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast.

R M Baird1, A Worth, G Hislop.   

Abstract

The morphologic subgroups of intraductal carcinoma in situ (DCIS) of the breast may be biologically different. Thirty-eight patients with comedo-type DCIS treated with local resection with or without radiotherapy are presented. Thirteen of 35 patients had a family history of breast cancer, with 11 patients having an affected first-degree relative. This is significantly increased over other series of breast cancer patients. Recurrence was ipsilateral in all patients and occurred at the site of the original disease. Recurrence occurred in 4 of 30 patients treated with local resection only and 2 of 8 treated with local resection plus radiotherapy. The length of mean follow-up was 39 months. Because of the paucity of studies, these results cannot be compared with others, but there does appear to be a significant incidence of local recurrence after resection for comedo-type DCIS. Immunohistochemical and oncogene studies as they relate to comedo-type DCIS are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2159245     DOI: 10.1016/s0002-9610(05)81250-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  Differential distribution of ErbB-2 and pS2 proteins in ductal carcinoma in situ of the breast.

Authors:  H Inaji; H Koyama; K Motomura; S Noguchi
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 2.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

Review 3.  The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast.

Authors:  Csaba Polgár; Zsuzsanna Kahán; Zsolt Orosz; Gabriella Gábor; Janaki Hadijev; Gábor Cserni; Janina Kulka; Nóra Jani; Zoltán Sulyok; György Lázár; Gábor Boross; Csaba Diczházi; Eva Szabó; Zsolt László; Zoltán Péntek; Tibor Major; János Fodor
Journal:  Pathol Oncol Res       Date:  2008-04-26       Impact factor: 3.201

4.  Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.

Authors:  S T Brower; S Ahmed; P I Tartter; I Bleiweiss; J B Amberson
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

5.  Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?

Authors:  Taeryung Kim; Heung Kyu Park; Kyung Hee Lee; Kwan Il Kim; Kyu Chan Lee; Jeong Suk Ahn; Kwang-Pil Ko
Journal:  Springerplus       Date:  2014-08-05

6.  DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy.

Authors:  H Beerman; B A Bonsing; M J van de Vijver; J Hermans; P M Kluin; R J Caspers; C J van de Velde; C J Cornelisse
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

7.  Evaluating the efficacy of post-surgery adjuvant therapies used for ductal carcinoma in situ patients: a network meta-analysis.

Authors:  Li Wang; Yaoxiong Xia; Dequan Liu; Yueqin Zeng; Li Chang; Lan Li; Yu Hou; Lv Ge; Wenhui Li; Zhijie Liu
Journal:  Oncotarget       Date:  2017-04-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.